QT Interval Effects Study of Oral FXS5626 Tablets

NCT07695779 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Evaluation of QTc Interval

Interventions

DRUG: FXS5626 tablet
DRUG: Placebo tablet

Sponsor

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.